Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-04-30

Clinical Trial Update: Effect of Milk Formula Supplemented With L. Reuteri on Crying Time in Colicky Infants Less Than 3 Months Old [Phase 4]

View source ↗

Summary

This clinical trial update covers a Phase 4 study evaluating whether milk formula supplemented with Lactobacillus reuteri reduces crying time in infants under 3…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lactobacillus reuteri (Lactobacillus reuteri)

Snippet

Sponsor: University of Bari | Conditions: Infantile Colic | Phase 4 | Status: UNKNOWN